TY - JOUR
T1 - Leptin kinetics during peritoneal dialysis in acutely uraemic rats
AU - Matsubara, Keisuke
AU - Kiyomoto, Hideyasu
AU - Moriwaki, Kumiko
AU - Hara, Taiga
AU - Kondo, Naoki
AU - Shokoji, Takatomi
AU - Hitomi, Hirofumi
AU - Aki, Yasuharu
AU - Aono, Masaki
AU - Nishiyama, Akira
AU - Ohmori, Koji
AU - Kohno, Masakazu
PY - 2004/10
Y1 - 2004/10
N2 - Background: Leptin has been shown to function as an inhibitor of appetite and energy expenditure accelerator. However, it was recently reported that leptin has other important functions as a fibrogenetic factor and a novel, independent risk factor for coronary heart disease. The present study aimed to assess the blood concentration of leptin in acute uraemic rats by using various peritoneal dialysis (PD) solutions. Methods: To induce acute renal failure, the bilateral renal arteries were ligated via a mid-abdominal incision 1 h before starting PD. Rats were divided into four groups: 13.6 g/L glucose-containing dialysate (group L); 38.6 g/L glucose-containing dialysate (group H); 13.6 g/L glucose- and 25 g/L mannitol-containing dialysate with equal osmotic pressure to the dialysate of group H (group M); and renal failure without PD (group F). The concentrations of glucose, urea nitrogen (UN), leptin and insulin were measured at 0, 2 and 4 h after starting PD. Results: We observed significant blood UN suppression in all dialysed groups. Blood glucose was significantly higher in rats treated with the high glucose solution than in those treated with the low glucose solution. Insulin and leptin significantly increased in the high glucose solution group. There was a strong correlation between the blood glucose and insulin levels. We also found a strong correlation between the percentage changes in blood glucose and leptin. The relationship between the percentage changes in insulin and leptin were weak but significant. Conclusion: The high glucose PD solution resulted in increased circulating levels of leptin, glucose, and insulin, suggesting that these changes are linked with PD performed with glucose-based dialysis fluid.
AB - Background: Leptin has been shown to function as an inhibitor of appetite and energy expenditure accelerator. However, it was recently reported that leptin has other important functions as a fibrogenetic factor and a novel, independent risk factor for coronary heart disease. The present study aimed to assess the blood concentration of leptin in acute uraemic rats by using various peritoneal dialysis (PD) solutions. Methods: To induce acute renal failure, the bilateral renal arteries were ligated via a mid-abdominal incision 1 h before starting PD. Rats were divided into four groups: 13.6 g/L glucose-containing dialysate (group L); 38.6 g/L glucose-containing dialysate (group H); 13.6 g/L glucose- and 25 g/L mannitol-containing dialysate with equal osmotic pressure to the dialysate of group H (group M); and renal failure without PD (group F). The concentrations of glucose, urea nitrogen (UN), leptin and insulin were measured at 0, 2 and 4 h after starting PD. Results: We observed significant blood UN suppression in all dialysed groups. Blood glucose was significantly higher in rats treated with the high glucose solution than in those treated with the low glucose solution. Insulin and leptin significantly increased in the high glucose solution group. There was a strong correlation between the blood glucose and insulin levels. We also found a strong correlation between the percentage changes in blood glucose and leptin. The relationship between the percentage changes in insulin and leptin were weak but significant. Conclusion: The high glucose PD solution resulted in increased circulating levels of leptin, glucose, and insulin, suggesting that these changes are linked with PD performed with glucose-based dialysis fluid.
KW - High glucose solution
KW - Leptin
KW - Peritoneal dialysis
KW - in vivo
UR - http://www.scopus.com/inward/record.url?scp=20844441937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20844441937&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1797.2004.00271.x
DO - 10.1111/j.1440-1797.2004.00271.x
M3 - Article
C2 - 15504136
AN - SCOPUS:20844441937
VL - 9
SP - 256
EP - 261
JO - Nephrology
JF - Nephrology
SN - 1320-5358
IS - 5
ER -